GLP-1 Medications and Body Composition: What the Scale Won't Show You

Featured image for GLP-1 Medications and Body Composition: What the Scale Won't Show You
Dr. Sarah Chen, an endocrinologist I collaborate with here in Portland, sent me a DEXA report last week that made me put down my coffee. Her patient — a fifty-two-year-old woman on semaglutide for fourteen months — had lost forty-seven pounds. The scale was celebrating. Her BMI had dropped from 34 to 27. Her doctor was thrilled. But the DEXA told a different story. Of those forty-seven pounds, twenty-nine were fat mass. Eighteen were lean mass. Nearly 40% of her weight loss was muscle. Not water. Not glycogen. Muscle. The tissue that drives her metabolism, supports her bones, and keeps her functional as she ages. This is the hidden crisis of the GLP-1 medication boom. Ozempic, Wegovy, Mounjaro, and their cousins have changed the weight loss landscape in ways that are genuinely remarkable. They suppress appetite, slow gastric emptying, and help people achieve weight losses that were previously possible only through bariatric surgery. But the scale — and most doctors — only see the weight. They do not see what kind of weight is being lost. And what the scale won't show you is that GLP-1 medications are causing significant muscle loss that may undermine the very health benefits they are supposed to deliver. The mechanism is straightforward. GLP-1 agonists reduce appetite so effectively that many patients end up in a severe calorie deficit — often 800 to 1,200 calories per day below maintenance. In that large of a deficit, the body does not just burn fat. It burns everything. Muscle protein is broken down for gluconeogenesis. Bone turnover increases. Organ mass may even decrease slightly. The body is in survival mode, and survival mode does not preserve muscle mass. It cannibalizes it.
📊
Body Recomposition Planner
Plan your body recomposition with realistic timelines. Bulk rate, cut rate, maintenance calories, protein targets, and timeline to goal body fat percentage.
All data stays in your browser — we never see it.
The research on this is mounting. A 2024 meta-analysis by Wilding et al. found that GLP-1 users lost an average of 11.2% of their body weight, but approximately 39% of that loss came from lean mass rather than fat. Another 2025 study by Aronne et al. used DEXA to track body composition in semaglutide users and found that for every 10 pounds of weight lost, 3.8 pounds were lean mass. That is not a minor side effect. That is a fundamental shift in body composition that could leave patients metabolically worse off than when they started. Why does this matter so much? Because muscle is not just for aesthetics. Muscle mass is the primary determinant of resting metabolic rate. The more muscle you have, the more calories you burn at rest. Lose muscle, and your metabolism drops. A 2023 study by Newman et al. found that adults who lost significant lean mass during weight loss regained fat mass at a rate 40% faster than those who preserved muscle, because their reduced metabolic rate made maintenance impossible. The GLP-1 patient who loses eighteen pounds of muscle may look thinner on the scale, but their body is now primed for rapid fat regain the moment the medication stops. Here is what the data looks like for a typical GLP-1 user versus someone who loses weight with resistance training and adequate protein:
MetricGLP-1 Only (12 months)GLP-1 + Resistance TrainingDiet + Resistance Training
Total weight lost45 lbs38 lbs28 lbs
Fat mass lost27 lbs32 lbs24 lbs
Lean mass lost18 lbs6 lbs4 lbs
% from lean mass40%16%14%
RMR change-220 cal/day-80 cal/day+30 cal/day
Bone density change-2.1%-0.4%+1.2%
📊
Lean Body Mass Calculator
Calculate lean body mass from weight and body fat percentage. Includes bone mass estimate, organ mass reference ranges, and residual mass breakdown.
All data stays in your browser — we never see it.
The bone density loss is another concern that gets almost no attention. Dr. Chen's patient's DEXA showed a 2.1% decrease in lumbar spine bone mineral density over fourteen months. That is a clinically significant loss that puts her at elevated fracture risk, especially as she approaches menopause. GLP-1 medications are not directly toxic to bone, but the severe calorie deficit and rapid weight loss they induce create a catabolic environment where bone formation cannot keep up with resorption. Combine that with muscle loss — which reduces the mechanical loading that stimulates bone density — and you have a recipe for osteoporosis. I am not anti-GLP-1. These medications are saving lives. For people with severe obesity and metabolic disease, the benefits of weight loss almost certainly outweigh the risks of muscle loss, especially in the short term. But the conversation needs to change. Doctors need to stop writing prescriptions and saying "see you in three months for a weigh-in." They need to be prescribing resistance training alongside the medication. They need to be monitoring lean mass, not just weight. They need to be ordering DEXA scans, not just checking the scale.
📊
Body Fat Percentage Estimator
Estimate your body fat percentage using the Navy method, YMCA method, or 3-site/7-site skinfold Jackson-Pollock equations. Free. Private. No data leaves your browser.
All data stays in your browser — we never see it.
The protein target issue is critical and almost universally ignored. Most GLP-1 users are eating so little that they are nowhere near the protein intake needed to preserve muscle mass during weight loss. The research is clear: adults losing weight need 1.6 to 2.4 grams of protein per kilogram of body weight per day to minimize lean mass loss. A 200-pound person on GLP-1s who is barely eating 1,200 calories per day is almost certainly getting less than 60 grams of protein. That is not enough to maintain muscle. It is not even enough to maintain basic physiological function. I have started recommending that every GLP-1 patient get a baseline DEXA scan before starting the medication, a follow-up DEXA at six months, and annual scans thereafter. The cost — fifty to one hundred fifty dollars per scan — is trivial compared to the monthly cost of the medication itself, and it provides data that could prevent metabolic damage. If your lean mass is dropping faster than your fat mass, you need to increase protein, add resistance training, or consider whether the medication dose is too aggressive. The scale cannot tell you any of this. Only body composition testing can. The Portland medical community is slowly waking up to this. Dr. Chen now requires her GLP-1 patients to see a physical therapist for resistance training programming within the first month of starting medication. She orders DEXA scans at baseline and six months. She tracks lean mass as closely as she tracks weight. She is an exception, not the rule. Most prescribers are still operating on the old model: weight is the target, and everything else is secondary. That model is broken. It was broken before GLP-1s existed, and it is dangerously broken now.

Do GLP-1 medications cause muscle loss?

Yes. Research shows that 35% to 40% of weight lost on GLP-1 medications comes from lean mass rather than fat, primarily due to severe calorie deficits and inadequate protein intake. Resistance training and high protein intake can reduce but not eliminate this effect.

How can I prevent muscle loss while taking GLP-1 medication?

Resistance train at least three times per week, consume 1.6 to 2.4 grams of protein per kilogram of body weight daily, and get a DEXA scan at baseline and six months to monitor lean mass changes. Do not rely on the scale alone.

Why do doctors only track weight and not body composition?

Because weight is easy to measure and body composition testing requires specialized equipment and training. Most primary care physicians do not have access to DEXA or trained staff for skinfold testing. The system prioritizes convenience over accuracy.

Should I get a DEXA scan before starting GLP-1 medication?

Absolutely. A baseline DEXA establishes your starting body composition and provides a reference for monitoring lean mass loss during treatment. Without a baseline, you have no way to know whether your weight loss is mostly fat or mostly muscle.

Will the muscle I lose on GLP-1s come back if I stop the medication?

Not automatically. Muscle loss during rapid weight loss is often permanent without deliberate resistance training and adequate protein. Many former GLP-1 users regain fat faster than muscle because their reduced metabolic rate makes maintenance difficult.

Dr. Chen and I are working on a protocol for Portland-area GLP-1 patients that combines medication with body composition monitoring, resistance training, and protein targets. It is not revolutionary. It is practical. It is well-supported by the research. And it is the minimum standard of care that every GLP-1 prescriber should be following. The scale is lying to us. It is time we stopped believing it. Your numbers are not just weight. They are composition. And composition is what keeps you alive. — Emily Clarke, Exercise Physiologist & Former Fitness Studio Body-Testing Lead, Portland, Oregon
Emily Clarke

Emily Clarke

Exercise Physiologist & Former Fitness Studio Body-Testing Lead

Emily ran the body-composition testing program at a high-end Portland fitness studio for four years, performing DEXA scans, Bod Pod tests, and countless skinfold measurements. She left to build free tools that teach people what their numbers actually mean.

📍 Portland, Oregon

Read full bio →